tirzepatide ending Shortage Ends FDA sets tirzepatide compounding deadlines

Weeks 5-6: Step down to 0.5 mg weekly

Include sources like avocados, nuts, seeds, and olive oil, but be mindful of portions since fats are calorie-dense

Insurance companies often deny coverage for Wegovy because they classify weight loss medications as cosmetic rather than medical treatment

The 2026 preprint is the first to directly test cognitive outcomes in a live aging model with a clean subcutaneous protocol

Despite these mixed results, Amgen is pushing forward with phase 3 trials for MariTide. You might wonder why, considering that the full phase 2 trial data only showed a mild improvement on Wegovy's average weight loss